Item 5. Other Information
Item
5. Other Information
None
- 28 -
Table of Contents
Item
6. Exhibits
(a) Exhibit
index
Exhibit
3.1
First Amendment to the Amended and Restated Bylaws of BioVie Inc. (incorporated
by reference to Exhibit 3.1 to the Current Report on Form 8-K (File No. 001-39015) filed on March 13, 2023)
10.1
Amendment
No. 2 to Asset Purchase Agreement, dated January 13, 2023, by and between BioVie Inc. and Acuitas Group Holdings, LLC, and Acuitas
Group Holdings, LLC, solely for purposes of Section 10.16 of the Agreement
31.1*
Certification
of Chief Executive Officer (Principal Executive Officer) required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange
Act of 1934, as amended.
31.2*
Certification
of Chief Financial Officer (Principal Financial Officer) required by Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange
Act of 1934, as amended.
32.1**
Certifications
of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**
Certification
of Chief Financial Officer (Principal Financial Officer) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002.
101.INS
XBRL
Instance Document
101.SCH
XBRL
Taxonomy Extension Schema Document
101.CAL
XBRL
Taxonomy Extension Calculation Linkbase Document
101.LAB
XBRL
Taxonomy Extension Label Linkbase Document
101.PRE
XBRL
Taxonomy Extension Presentation Linkbase Document
101.DEF
XBRL
Taxonomy Extension Definition Linkbase Document
*
Filed
herewith.
**
Furnished
herewith. This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. Section 1350, and is not being
filed for purposes of Section 18 of the Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filings
of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
- 29 -
Table of Contents
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
BioVie
Inc.,
Signature
Titles
Date
/s/
Cuong V Do
Cuong
V Do
Chairman
and Chief Executive Officer (Principal Executive Officer)
May
12, 2023
/s/
Joanne Wendy Kim
Joanne
Wendy Kim
Chief
Financial Officer (Principal Financial and Accounting Officer)
May
12, 2023
- 30 -
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.